elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37152580-1F1D197A-587A-489E-A4C2-86479D538A31
Q37152580-1F1D197A-587A-489E-A4C2-86479D538A31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37152580-1F1D197A-587A-489E-A4C2-86479D538A31
Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemia
P2860
Q37152580-1F1D197A-587A-489E-A4C2-86479D538A31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37152580-1F1D197A-587A-489E-A4C2-86479D538A31
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
71a05f28d9628879294cc4dc93f1324758eec566
P2860
The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.